81 results
DEFA14A
SYRS
Syros Pharmaceuticals Inc.
23 Apr 24
Additional proxy soliciting materials
7:05am
encourage you to access and review all of the important information contained in the proxy materials before voting. The 2024 proxy statement and annual … report to stockholders are available at: www.envisionreports.com/SYRS Easy Online Access — View your proxy materials and vote. Step 1: Go
PRE 14A
SYRS
Syros Pharmaceuticals Inc.
12 Apr 24
Preliminary proxy
4:30pm
[ ], 2024 to all stockholders entitled to vote at the annual meeting. We have elected to provide access to our proxy materials over the Internet … under the Securities and Exchange Commission’s “notice and access” rules. We believe that providing our proxy materials over the Internet expedites
8-K
EX-1.1
SYRS
Syros Pharmaceuticals Inc.
19 Dec 23
Syros Announces Pricing of $45.0 million Underwritten Offering of Common Stock and Pre-Funded Warrants
4:59pm
of financial statements in conformity with GAAP and to maintain accountability for assets; (iii) access to assets is permitted only in accordance … and IT System Data and to the protection of such IT Systems and IT System Data from unauthorized use, access, misappropriation or modification.
(bbb
8-K
EX-99.2
f0k36cwkynuz2i
6 Dec 23
Regulation FD Disclosure
7:05am
8-K
EX-99.1
pxr8ytrn81x60r e6
25 May 23
Regulation FD Disclosure
5:10pm
DEFA14A
qdy2w69dzcamd7l3psfu
21 Apr 23
Additional proxy soliciting materials
7:03am
8-K
EX-99.1
kti o1hqym
12 Dec 22
Regulation FD Disclosure
7:48am
8-K
EX-99.2
yjqbjdw3
12 Dec 22
Regulation FD Disclosure
7:48am
424B3
iz06i5d1ibizd 8y6n2p
8 Aug 22
Prospectus supplement
5:47pm
S-4/A
EX-99.2
7z38jf0 bkhxrqi3ts
1 Aug 22
Registration of securities issued in business combination transactions (amended)
9:01am
S-4/A
EX-99.1
fndt09 c21e1995
1 Aug 22
Registration of securities issued in business combination transactions (amended)
9:01am